<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent studies have found that blockers of <z:chebi fb="0" ids="26831">sulfonylureas</z:chebi> receptor 1(SUR1) might have cardiac ischemic protective effects </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluated the effects of a selective SUR1 blocker <z:chebi fb="0" ids="31654">gliclazide</z:chebi> on cardiac function and <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> after <z:chebi fb="0" ids="6046">isoprenaline</z:chebi>-induced myocardial injury in <z:mp ids='MP_0001261'>obese</z:mp> rats </plain></SENT>
<SENT sid="2" pm="."><plain>Diet-induced <z:mp ids='MP_0001261'>obese</z:mp> rats received <z:chebi fb="0" ids="6046">isoprenaline</z:chebi> or saline shots subcutaneously </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="31654">Gliclazide</z:chebi> or saline was given q12 h for 48 h to rats received <z:chebi fb="0" ids="6046">isoprenaline</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>We measured ECG and hemodynamic parameters and collected blood samples for CK-MB, <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="23" ids="18059">lipid</z:chebi> profile determination, and then harvested hearts for water content, histological and immunohistochemical analysis and <z:mpath ids='MPATH_124'>infarct</z:mpath> size measurements </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:mp ids='MP_0001261'>obese</z:mp> rats' hearts receiving <z:chebi fb="0" ids="6046">isoprenaline</z:chebi>-induced myocardial injury showed up-regulated SUR-1 expression in the peri-microvascular area </plain></SENT>
<SENT sid="6" pm="."><plain><z:mp ids='MP_0001261'>Obese</z:mp> rats receiving <z:chebi fb="0" ids="31654">gliclazide</z:chebi> lavage had less severe <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> (ASI: 4.00 ± 0.61 vs. 2.14 ± 0.39, P&lt;0.05) and myocardial <z:hpo ids='HP_0000969'>edema</z:hpo> (water percentage: 85.16 ± 0.46% vs. 81.56 ± 0.57%, P&lt;0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Less <z:mpath ids='MPATH_124'>infarct</z:mpath> size (47.6 ± 12.8% vs. 32.7 ± 9.1%, P&lt;0.05) and improved diastolic function (LVEDP: 6.86 ± 0.85% vs. 2.51 ± 1.09%, P&lt;0.05;-(dp/dt)(max): -1663.6 ± 387.91 mmHg/s vs. -2834.8 ± 290.76 mmHg/s, P&lt;0.05) were also observed in rats receiving <z:chebi fb="0" ids="31654">gliclazide</z:chebi> lavage </plain></SENT>
<SENT sid="8" pm="."><plain>Blocking of the SUR1 thus exerts a protective effect on the <z:chebi fb="0" ids="6046">isoprenaline</z:chebi>-induced myocardial injury in <z:mp ids='MP_0001261'>obese</z:mp> rats </plain></SENT>
<SENT sid="9" pm="."><plain>That SUR1 blocker leads to ischemic protection suggesting a critical biological role of SUR1 in regulating the function of the cardiovascular system than previously recognized under pathophysiological conditions </plain></SENT>
</text></document>